Nokia NOK Secures UK Appeal Victory in Video Patent Dispute with Acer and Asus Morgan Stanley Lowers Edison International Price Target Amid Utility Sector Review Google Pixel Launch Sparks Privacy Concerns Over AI Assistant Data Practices Political Scandal Over Film Funding Casts Doubt on Flvio Bolsonaros Presidential Campaign Genpact CEO Warns of AIDriven IT Workload Reduction and Slower Hiring in India Trump Urges New Fed Chair Kevin Warsh to Be Totally Independent Amid Rate Cut History CCM Q2 2016 Earnings Significant EPS Miss Amid Operational Challenges AEMD Q1 2026 Earnings Narrower Slight Loss Surprise Supports Share Recovery Colony Bankcorp CBAN Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Modest Stock Gain SVCO Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 274 FFAI Q1 2026 Earnings Narrowed Losses Beat Estimates but No Revenue Reported and Stock Drops 981 FCRX Q1 2026 Earnings Narrow Miss on EPS Stable Note Performance Arbor Realty Trust ABR Slides 296 as Support Levels Come into Focus Dragonfly Energy Holdings DFLI Holds Steady at 214 as Key Levels Define Trading Range Pimco High Income Fund PHK Holds Steady Near Support as Yield Focus Persists US Global Investors GROW Edges Higher Navigating Support and Resistance Levels Draganfly DPRO Shares Edge Higher Support Tested as Drone Maker Eyes Resistance DraftKings Stock Declines Following Cautious Revenue Outlook Bio Green Med Solution Inc Q3 2024 Earnings Narrowed Loss Beats Estimates Shares Fall on Revenue Uncertainty SuperX AI Technology SUPX Jumps 798 Key Levels to Watch SLS Q1 2026 Earnings WiderThanExpected Loss as Clinical Milestones Remain the Focus PENG Q1 2026 Earnings Strong EPS Beat Drives 9 Surge TIPT Q2 2025 Earnings EPS of 058 Reported Amid Modest Stock Decline SWAG Q1 2026 Earnings Profitability Milestone with Positive EPS PM Q1 2026 Earnings Earnings Beat on Margin Strength SmokeFree Momentum Continues UTHR Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Immatics NV IMTX Q1 2026 Earnings EPS Misses Estimates as Clinical Progress Drives Share Gains